摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

menthyl (triphenylphosphoranylidene)acetate

中文名称
——
中文别名
——
英文名称
menthyl (triphenylphosphoranylidene)acetate
英文别名
[(1R,2S,5R)-5-methyl-2-propan-2-ylcyclohexyl] 2-(triphenyl-lambda5-phosphanylidene)acetate;[(1R,2S,5R)-5-methyl-2-propan-2-ylcyclohexyl] 2-(triphenyl-λ5-phosphanylidene)acetate
menthyl (triphenylphosphoranylidene)acetate化学式
CAS
——
化学式
C30H35O2P
mdl
——
分子量
458.58
InChiKey
BAZBQYTXRXBCKK-OFQAEJFBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.5
  • 重原子数:
    33
  • 可旋转键数:
    7
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    menthyl (triphenylphosphoranylidene)acetate盐酸羟胺sodium acetate 作用下, 以 二氯甲烷乙腈 为溶剂, 反应 23.0h, 生成 (L)-Menthyl trans-hept-2-enoate-7-al oxime
    参考文献:
    名称:
    X = Y - ZH systems as potential 1,3-dipoles part 35. Generation of nitrones from oximes. Class 3 processes. Tandem intramolecular michael addition (1,3-azaprotio cyclotransfer) - intermolecular 1,3-dipolar cycloaddition reactions.
    摘要:
    Aldoximes and ketoximes possessing gamma- or delta-alkenyl substituents undergo thermal conversion to 5- and 6- membered cyclic nitrones via a 1,3-azaprotio cyclotransfer, a 2n + 2-sigma + 2-pi concerted process, rather than a Michael addition. The reactions can be performed as a tandem nitrone formation-cycloaddition sequence or, if required, the intermediate nitrones can be isolated. The cycloadditions usually proceed via an exo-transition state and show both regio- and diastereofacial-specificity. Preliminary attempts at chiral induction via a menthyl auxiliary are reported.
    DOI:
    10.1016/s0040-4020(01)89883-5
  • 作为产物:
    描述:
    (1R,2S,5R)-menthol bromoacetate 在 sodium hydroxide 作用下, 以 四氢呋喃甲苯 为溶剂, 反应 5.58h, 生成 menthyl (triphenylphosphoranylidene)acetate
    参考文献:
    名称:
    Synthesis and structure–activity relationship studies of novel tubulysin U analogues – effect on cytotoxicity of structural variations in the tubuvaline fragment
    摘要:
    Tubulysins是一种细胞毒性天然产物,具有有前景的抗癌特性,最初从粘细菌培养物中分离出来。在结构上,Tubulysins是四肽,包含三个不寻常的(Mep、Tuv和Tup)和一个蛋白质原生的氨基酸(Ile)。在这里,我们描述了新型Tubulysin U和V类似物的合成及其构效关系研究,这些类似物在中央Tuv片段上有所变化,该片段对于Tubulysins的效力和细胞毒性至关重要,但在先前的研究中很少被修改。具体而言,我们用其他结构相关的基团替代了天然的异丙基和乙酰氧基功能。总的来说,与天然Tubulysin U相比,新的类似物显示出较低的效力。然而,其中一个合成类似物(1f)具有MOM功能替代乙酰基,在HT-29细胞系上显示出22 nM的IC50,与Tubulysin U(3.8 nM)显示的IC50相当。此外,本文报道的合成方法被发现足够灵活,可以提供不同核心修饰的Tubulysin类似物,因此可以被视为产生新型Tubulysins类似物的可扩展和便捷策略。
    DOI:
    10.1039/c3ob27111k
点击查看最新优质反应信息

文献信息

  • [EN] A CONJUGATE OF A TUBULYSIN ANALOG WITH BRANCHED LINKERS<br/>[FR] CONJUGUÉ D'UN ANALOGUE DE TUBULYSINE AVEC DES LIEURS RAMIFIÉS
    申请人:HANGZHOU DAC BIOTECH CO LTD
    公开号:WO2019127607A1
    公开(公告)日:2019-07-04
    The present invention relates to the conjugation of a tubulysin analog compound to a cell-binding molecule with branched/side-chain linkers for having better delivery of the conjugate compound and targeted treatment of abnormal cells. It also relates to a branched-linkage method of conjugation of a tubulysin analog molecule to a cell-binding ligand, as well as methods of using the conjugate in targeted treatment of cancer, infection and autoimmune disease.
    本发明涉及将一种管腔霉素类似物化合物与具有分支/侧链连接物的细胞结合分子结合,以实现结合物的更好传递和靶向治疗异常细胞。它还涉及一种将管腔霉素类似物分子与细胞结合配体结合的分支连接方法,以及在靶向治疗癌症、感染和自身免疫疾病中使用结合物的方法。
  • Synthesis and Superpotent Anticancer Activity of Tubulysins Carrying Non-hydrolysable N-Substituents on Tubuvaline
    作者:Monica Sani、Paolo Lazzari、Marco Folini、Marco Spiga、Valentina Zuco、Michelandrea De Cesare、Ilaria Manca、Sergio Dall'Angelo、Massimo Frigerio、Igor Usai、Andrea Testa、Nadia Zaffaroni、Matteo Zanda
    DOI:10.1002/chem.201700874
    日期:2017.4.27
    antimitotic activity and induced apoptosis in cancer cells at very low concentrations. Compound 24 e also exhibited potent antitumor activity at well tolerated doses on in vivo models of diffuse malignant peritoneal mesothelioma, such as MESOII peritoneal mesothelioma xenografts, the growth of which was not significantly affected by vinorelbine. These results indicate that synthetic tubulysins 24 could
    合成的微管蛋白24 a – m包含微管蛋白(Tuv)上不可水解的N取代基,可通过多步合成获得高纯度和良好的总收率。一个关键步骤是通过使用叠氮基-Ile衍生物8与α,β-不饱和氧代-噻唑5的aza-Michael反应形成不同的N-取代的Ile-Tuv片段10。使用一组人类肿瘤细胞系进行的结构-活性关系研究表明,所有化合物24 a – m具有很强的抗增殖活性,IC 50亚纳摩尔范围内的值明显低于微管蛋白A,长春瑞滨和紫杉醇的值。此外,在两个对阿霉素具有耐药性的肿瘤细胞系中,24 a – m能够克服对紫杉醇和长春瑞滨的交叉耐药性。选择化合物24e和24g作为先导,以评估其作用机理。体外测定表明,24 e和24 g都以长春花样生物碱的方式干扰微管蛋白的聚合,并阻止了紫杉醇诱导的微管蛋白聚合物的组装。两种化合物均以极低的浓度发挥抗有丝分裂活性并诱导癌细胞凋亡。化合物24 e在弥漫性恶性腹膜间皮瘤的体
  • Cycloaddition of Fluorenone <i>N</i>-Aryl Nitrones with Methylenecyclopropanes and Sequential 1,3-Rearrangement: An Entry to Synthesis of Spirofluorenylpiperidin-4-ones
    作者:Xiao-Pan Ma、Jie-Feng Zhu、Si-Yi Wu、Chun-Hua Chen、Ning Zou、Cui Liang、Gui-Fa Su、Dong-Liang Mo
    DOI:10.1021/acs.joc.6b02544
    日期:2017.1.6
    highly selective 1,3-rearrangement to give the desired product. The stereochemistry of the spirofluorenylpiperidin-4-one could be controlled by the cycloaddition and sequential rearrangement strategy. Furthermore, the spirofluorenylpiperidin-4-ones could be not only prepared in one-pot procedure but also converted to useful scaffolds by reduction or oxidation conditions.
    从芴酮N-芳基硝酮和亚甲基环丙烷可以容易地合成各种螺芴基哌啶-4-酮。该方法涉及初始的环加成反应以形成5-螺环丙烷-异恶唑啉,对其进行高度选择性的1,3-重排以得到所需的产物。螺芴基哌啶-4-酮的立体化学可通过环加成和顺序重排策略控制。此外,螺芴基哌啶-4-酮不仅可以一锅法制备,而且还可以通过还原或氧化条件转化为有用的支架。
  • The first practical approach to optically pure cyclopropanes derived from trans γ-hydroxy enones
    作者:Francine N. Palmer、Dennis K. Taylor
    DOI:10.1039/b001973i
    日期:——
    A new approach for the synthesis of optically pure cyclopropanes from trans γ-hydroxy enones and stabilised phosphorus ylides is presented; the use of light and a triplet sensitiser leads to a dramatic increase in reaction rate and isolated yield.
    一种新的方法被提出,用于从反式γ-羟基烯酮和稳定磷叶立德合成光学纯的环丙烷;使用光和三重态敏化剂显著提高了反应速率和分离产率。
  • PHARMACEUTICAL COMPOSITIONS
    申请人:ZANDA Matteo
    公开号:US20110200581A1
    公开(公告)日:2011-08-18
    Synthesis natural tubulisine derivatives of formula (A) having a high cytotoxicity wherein: B is selected from CH 2 , CH 2 —CH 2 or CH 2 —CH 2 —CH 2 , D is an aromatic linker, X 1 is alkyl or alkenyl, X 2 is selected from the X 2a , substituted or non substituted, selected from: aryl, heteroaryl, arylalkyl, cycloalkylalkyl, heterocycloalkylalkyl, or heteroarylalkyl, X 2b : alkylene-O-alkyl, wherein alkylene is C 2 -C 10 , X 2c : CH 2 —O-alkyl, X 3 is selected from H, or together with X 4 forms the group ═O, X 4 is selected from H, halogen, OH, SH, alkyl, alkenyl, (OR 5 ) n —OR 6 , OC(O)R 7 , NR 6 R 7 , or together with X 4 forms the group ═O, R 5 is an alkylene, n is zero or an integer from 1 to 10, R 6 and R 7 , equal to or different from each other, have the following meanings: z1: H, alkyl, z2 substituted or non substituted: aryl, heteroaryl, cycloalkyl, heterocycloalkyl, arylalkyl, heteroarylalkyl, cycloalkylalkyl, heterocycloalkylalkyl, X 5 is z2, or has the meaning of z3=alkyl, alkenyl, X 6 is selected from NR 8 R 9 , OR 8 , NH—NR 8 R 9 , SR 8 , R 10 , wherein R 8 and R 9 , equal to or different from each other, have the same meanings of R 8 , R 10 has the same meanings as R 6 but excluding H, X 7 is z3 or H, X 8 is selected from z3, H, halogen, OH, SH, OCH 3 .
    合成具有高细胞毒性的具有以下结构的天然管状素衍生物(A)其中:B从CH2、CH2—CH2或CH2—CH2—CH2中选择,D是芳香连接体,X1是烷基或烯基,X2从X2a中选择,替代或未替代,从中选择:芳基、杂环芳基、芳基烷基、环烷基烷基、杂环烷基烷基或杂环芳基烷基,X2b:烷基氧烷基,其中烷基是C2-C10,X2c:CH2—氧烷基,X3从H中选择,或与X4一起形成═O基团,X4从H、卤素、羟基、硫基、烷基、烯基、(OR5)n—OR6、OC(O)R7、NR6R7中选择,或与X4一起形成═O基团,R5是烷基,n为零或1至10之间的整数,R6和R7,彼此相等或不同,具有以下含义:z1:H、烷基,z2替代或未替代:芳基、杂环芳基、环烷基、杂环烷基、芳基烷基、杂环芳基烷基、环烷基烷基、杂环烷基烷基,X5是z2,或具有z3=烷基、烯基的含义,X6从NR8R9、OR8、NH—NR8R9、SR8、R10中选择,其中R8和R9,彼此相等或不同,具有R8的相同含义,R10具有与R6相同但不包括H的含义,X7是z3或H,X8从z3、H、卤素、羟基、硫基、OCH3中选择。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐